24,000 Registered Attendees Fill the Halls of Successful SPIE Photonics West 2025
10.2.2025 20:55:00 CET | Business Wire | Press release
The largest annual optics and photonics event of the year highlighted exciting new research, networking, and the latest in photonics products and industry trends
SPIE, the international society for optics and photonics, registered 24,000 optics and photonics professionals from over 75countries for Photonics West, as the Society hosted the largest international annual photonics meeting at San Francisco’s Moscone Center. The dynamic week, which ran from 25 to 30 January, featured 1,588 exhibitors and 5,000 technical presentations across four focused tracks – BiOS, LASE, OPTO, Quantum West – four exhibitions, and the co-located AR | VR | MR conference.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250210056991/en/

SPIE Photonics West 2025 exhibition opens for business at San Francisco's Moscone Center. (Photo: Business Wire)
“Photonics West marks the start of the optics and photonics calendar every year,” said SPIE CEO Kent Rochford. “And this year, it also marked a truly exciting milestone for SPIE as the Society’s Membership surpassed 25,000! In addition, our newest conference, Quantum West, continues to grow, reflecting the ongoing development of this exciting technological area and its many applications. Throughout the week, Photonics West 2025 proved to be a terrific meeting of minds, showcasing the varied ways optics and photonics technologies are impacting our lives, and now I’m looking forward to Photonics West 2026, an event which is already in the works.”
As always, the action-filled week showcased the latest innovative technologies and discoveries stemming from a diverse and thriving optics and photonics community, bringing together researchers, innovators, engineers, entrepreneurs, and business leaders from across the globe. More than 100 technical conferences complemented the four exhibitions, bringing researchers and companies together to further science, technology, and applications. The week also included a wide range of live product demonstrations on the exhibition floors as well as a job fair.
The SPIE Industry Program continues to highlight key and critical areas. The SPIE Global Business Forum – which brings together top industry executives for high-level presentations, networking, and conversations – was once again a sold-out success. The glamorous Prism Awards, now in its 17th year, celebrated the best new optics and photonics products, while the inspiring Startup Challenge pitch competition recognized three exciting emerging photonics companies. And at the Quantum West Business Summit, speakers and panelists discussed the current trends in this rapidly growing technical and commercial arena.
In addition, 52 educational courses offered expert-led technical training and learning, complementing the many various professional development and networking opportunities on offer throughout the week: From the Lunchtime Professional Development Education series to social events, Photonics West featured a packed calendar of meet-ups, canine-focused relaxation time, and interactive, collaborative gatherings. And in conjunction with Photonics West, SPIE celebrated 20 years of its Women in Optics notebook, bringing together such luminaries as Ursula Keller, Muyinatu "Bisi" Bell, and Jessica Wade for a day-long event of speakers, panelists, and conversations.
While the week held myriad opportunities for attendees to learn, network, and share their latest advancements, it was the buzzing exhibitions – BiOS Expo, the Photonics West exhibition, the Quantum West Expo, and the AR | VR | MR exhibition – that best showcased the increasingly critical photonics industry and the importance of in-person meetings.
“We started out very fast, very busy right off the jump,” said Optikos Director of Operations Dennis Fantone. “It’s been really exciting connecting with old colleagues and friends that hadn’t been to the show before or hadn’t been in a few years. And this is also a great place to meet up not just with customers but with vendors as well: It’s great to get the personal touch that you just get over email and phone.”
“We’ve had really good traffic and have been able to see old customers and suppliers as well as making new contacts,” said Wasatch Photonics Senior Optical Engineer Elroy Pearson. “Photonics West has been really fruitful.”
“I’ve been going to Photonics West ever since it was a tiny, tiny show in San Jose,” said NKT President and CEO Basil Garabet. “We like this show – for us it’s the big show in the US. And because we are very much into the medical and bio area, being at BiOS as well is good for us. We like the position we’re in on the show floor because we don’t have to move – so that works really well for us: we just set up one booth for both shows. Now we are part of Hamamatsu, and they are right across the way, so again that’s worked out really well for us. It’s altogether good, and we look forward to it when we come over. It’s been a very good week.”
“Photonics West 2025 has highlighted the industry’s strong focus on precision, integration, and scalability in optical and photonic technologies,” noted Dr. Efstratios (Stratos) Kehayas, President, Photonics at G&H. “We’ve seen significant interest in advanced laser beam shaping, integrated photonics for compact systems, and high-reliability optical components for demanding applications in industrial, laser fusion and life sciences. The conversations at our booth reflect a growing demand for solutions that enhance performance while addressing challenges in power efficiency, miniaturization, and system integration.”
During the Photonics West week, SPIE also announced its latest SPIE Endowment Matching Program partnerships, one with Boston University and another with National University of Singapore.
As SPIE Director of Sales Jeff Nichols points out, even after this exciting week, there’s so much to look forward to. “The week of Photonics West has always been the best place to see the size and scope of our industry,” notes Nichols. “And in 2026, we're thrilled to be adding VisionTech, a new exhibit and technical program that will showcase the photonics technologies enabling the imaging and vision markets. With the continued growth of Photonics West, SPIE is turning San Francisco in January into a single stop for anyone interested in the latest advancements in photonics technologies and the numerous applications that they enable.”
SPIE Photonics West 2026 will take place 17-22 January at the Moscone Center in San Francisco. The call for papers for the 2026 event will open in Spring of 2025.
About SPIE
SPIE, the international society for optics and photonics, brings engineers, scientists, students, and business professionals together to advance light-based science and technology. The Society, founded in 1955, connects and engages with our global constituency through industry-leading conferences and exhibitions; publications of conference proceedings, books, and journals in the SPIE Digital Library; and career-building opportunities. Over the past five years, we have invested more than $25 million in the international optics community through our advocacy and support, including scholarships, educational resources, travel grants, endowed gifts, and public-policy development. www.spie.org.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250210056991/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex to Present New Data on ALYFTREK® at the North American Cystic Fibrosis Conference9.10.2026 19:15:00 CEST | Press release
- Data on ALYFTREK in children ages 2 to 5 years demonstrate recovery of pancreatic function in some children –- Additional abstracts on clinical and real-world evidence on CFTR modulators also presented - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) 2 to 5 years old open-label extension study, highlighting recovery of exocrine pancreatic function in some children in that age group, allowing those children to discontinue pancreatic enzyme replacement therapy (PERT). Pancreatic exocrine insufficiency in children with cystic fibrosis (CF) was previously believed to be irreversible. These data were presented at the North American Cystic Fibrosis Conference (NACFC). “The data presented at NACFC underscore the safety and efficacy of our CF medicines in the real world and in clinical trials in younger age groups. The data from the Phase 3 open-label study in 2 to 5 year olds evaluating exocrine p
Andersen Consulting udvider med TalentSmartEQ for at fremme lederskab og virksomhedstransformation9.10.2026 18:48:00 CEST | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for humankapital gennem en samarbejdsaftale med TalentSmartEQ, en San Diego-baseret virksomhed, der har fokus på at skabe praktiske, engagerende og handlingsorienterede læringsoplevelser med udgangspunkt i emotionel intelligens (EQ) og lederudvikling. I mere end to årtier har TalentSmartEQ arbejdet sammen med organisationer verden over med henblik på at udvikle ledelseskompetencer ved hjælp af emotionel intelligens og dermed styrke medarbejderengagement, teamwork og de samlede resultater. Virksomheden kombinerer forskningsbaserede metoder med praktiske læringsforløb, vurderinger, coaching og skræddersyede programmer, der skal omsætte opbygningen af emotionel intelligens til vedvarende ændringer i adfærden på arbejdspladsen. Som førende aktør i branchen samarbejder TalentSmartEQ med organisationer lige fra Fortune 500-virksomheder til offentlige myndigheder og privatejede virksomheder. "Organisationer stiller stadig større krav til dere
Verdant Rock Receives A (low) Financial Strength Rating from Morningstar DBRS, Adding a Second International Investment-Grade Assessment9.10.2026 16:00:00 CEST | Press release
Verdant Rock now holds Financial Strength Ratings from both Fitch Ratings and Morningstar DBRS, providing counterparties with dual-agency confirmation and reinforcing the security architecture behind each financial guarantee Verdant Rock Limited, a Bermuda Monetary Authority-regulated Class 3B insurance company, has received an A (low) Financial Strength Rating from Morningstar DBRS. The rating reflects Verdant Rock’s financial strength and its capacity to meet policyholder obligations as an investment-grade financial guarantor for Emerging Markets credit. Morningstar DBRS is a global credit rating agency with coverage across North America, Europe, Asia, and Latin America. Its assessment of Verdant Rock reflects the company’s strong projected earnings ability, robust risk profile, sound liquidity, and good capitalization. Morningstar DBRS also assigned an A (low) Issuer Rating to Verdant Rock. The rating follows Verdant Rock’s BBB+ Long-Term Insurer Financial Strength Rating with a Sta
Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions9.10.2026 15:17:00 CEST | Press release
We think Gartner recognizes Tecnotree's open, governed approach to agentic AI as operators make AI the engine of their revenue operations Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, today announced that Gartner has positioned it as a Visionary in the first-ever Magic Quadrant for AI-Enabled CSP Marketing and Sales Solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261009905430/en/ Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions A new category for a new operating model. CSPs are fighting saturated markets, rising acquisition costs, and accelerating churn. They are responding with AI-driven automation across the full revenue cycle, from segmentation and campaigns to lead management, CPQ, and renewals, increasingly executed by autonomous agents. According to us, Gartner creation of this Magi
Positive New Data on Corcym’s Perceval Plus Sutureless Aortic Heart Valve Encompasses up to 7-Year Follow-up9.10.2026 15:15:00 CEST | Press release
Data Presented at Annual Meeting of European Association for Cardio-Thoracic Surgery (EACTS), Along with 6 Perceval Plus E-PostersEACTS Also Marks Commercial Launch of TriMemo and Memo 4D Curve, Innovative Repair Devices for Tricuspid and Mitral Valves Corcym, a global medical device company dedicated to cardiac surgery, today announced that positive mid-term data from a sub-analysis of its Perceval Plus sutureless aortic heart valve as part of its MANTRA clinical trial was featured in an oral presentation today at the annual meeting of the European Association for Cardio-Thoracic Surgery (EACTS). The study is the longest follow-up available for Perceval Plus and the FREE tissue treatment from an international multicenter study, and demonstrated excellent durability, safety and quality of life improvements. Perceval Plus is the only sutureless and collapsible aortic surgical heart valve. Its unique design performs in any surgical scenario and is optimal for endoscopy and robotics. The
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom